JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Obara, Y.
Right arrow Articles by Ohizumi, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Obara, Y.
Right arrow Articles by Ohizumi, Y.

Vol. 301, Issue 3, 803-811, June 2002


beta -Eudesmol Induces Neurite Outgrowth in Rat Pheochromocytoma Cells Accompanied by an Activation of Mitogen-Activated Protein Kinase

Yutaro Obara, Takashi Aoki, Masayoshi Kusano and Yasushi Ohizumi

Department of Pharmaceutical Molecular Biology, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba, Aramaki, Aoba-ku, Sendai, Japan

    Abstract
Top
Abstract
Introduction
Experimental Procedures
Results
Discussion
References

beta -Eudesmol, a sesquiterpenoid isolated from "So-jutsu" (Atractylodis lanceae rhizomas), is known to have various unique effects on the nervous system. We examined in detail the mechanism by which beta -eudesmol modified neuronal function using rat pheochromocytoma cells (PC-12). beta -Eudesmol at concentrations of 100 and 150 µM significantly induced neurite extension in PC-12 cells, which was accompanied, at the highest concentration, by suppression of [3H]thymidine incorporation. beta -Eudesmol at concentrations of 100 and 150 µM also evoked a significant increase in intracellular Ca2+ concentration ([Ca2+]i) in these cells, as determined by the fura 2 assay. Much of this increase remained even after the extracellular Ca2+ was chelated by EGTA. The [Ca2+]i increase induced by beta -eudesmol was partially inhibited by the phosphoinositide-specific phospholipase C (PI-PLC) inhibitor 1-[6-[[17beta -methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione (U-73122) (2 µM) under extracellular Ca2+-free conditions. Furthermore, beta -eudesmol, in a concentration-dependent fashion, caused an accumulation of inositol phosphates. beta -Eudesmol (150 µM) promoted phosphorylation of both mitogen-activated protein kinase (MAPK) and cAMP-responsive element binding protein in a time-dependent manner. These phosphorylations were suppressed by the MAPK kinase inhibitor 2-(2'-amino-3'-methoxyphenol)-oxanaphthalen-4-one (PD98059) (50 µM), U-73122 (2 µM), the calmodulin inhibitor N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide hydrochloride (W7) (1-10 µM), and the protein kinase A inhibitor N-[2-(4-bromocinnamylamino)ethyl]-5-isoquinoline (H89) (1-10 µM). beta -Eudesmol-induced neurite extension was significantly inhibited by both U-73122 (2 µM) and PD98059 (30 µM), suggesting the involvement of PI-PLC and MAPK in neurite outgrowth. beta -Eudesmol, being a small molecule, may therefore be a promising lead compound for potentiating neuronal function. Furthermore, the drug may be useful in helping to clarify the mechanisms underlying neuronal differentiation.

    Introduction
Top
Abstract
Introduction
Experimental Procedures
Results
Discussion
References

The central nervous system consists of neurons and glial cells. Neurons play a central role in signal transduction by releasing neurotransmitters. One of the most important characteristics of neurons is that they cannot, in general, proliferate once they have begun the process of differentiation. For this reason, neurotrophic factors are essential for the functional maintenance and organization of neurons. In the central nervous system, neurons and glial cells secrete neurotrophic factors, such as nerve growth factor (NGF), brain-derived neurotrophic factor, neurotrophin 3 (Lessmann, 1998; Althaus and Richter-Landsberg, 2000), interleukin-6 (Schwaninger et al., 1997), and glial cell line-derived neurotrophic factor (Lin et al., 1993). NGF has pleiotrophic effects on neuronal differentiation and survival (prevention of apoptosis) in a variety of neurons (Levi-Montalcini, 1987).

Rat pheochromocytoma cells (PC-12) have been used as an in vitro model of neuronal differentiation. In response to NGF, these cells extend neurites and develop characteristics of sympathetic neurons (Greene and Tischler, 1976). We have previously reported that a new neurotrophic factor secreted from 1321N1 human astrocytoma cells caused the differentiation of PC-12 cells (Obara et al., 1998). In addition, we have shown that 1321N1 cell culture medium, conditioned by scabronines isolated from Sarcodon scabrosus, enhanced the differentiation of PC-12 cells (Obara et al., 1999a, 2001).

"So-jutsu" (Atractylodis lanceae rhizomas), an often prescribed and important group of Chinese medicines, has various health effects, including the normalization of stomach and intestinal functions and the promotion of diuresis. Sesquiterpenoids, such as beta -eudesmol, hinesol, and elemol, were isolated from So-jutsu and reported to have unique effects on the nervous system. A mixture of beta -eudesmol and hinesol was shown to act as a sedative, to prolong sleep induced by hexobarbital, and to have anti-convulsive effects in mice exposed to electrical stimulation (Yamahara et al., 1977). The mechanism by which beta -eudesmol mediated these effects has been partially clarified. Thus, Satoh et al. (1992) showed that beta -eudesmol inhibited Na+, K+-ATPase activity, whereas Kimura et al. (1991) demonstrated that it acted as a channel blocker for the nicotinic acetylcholine receptor in skeletal muscle cells. Furthermore, Tachikawa et al. (2000) showed that acetylcholine-induced catecholamine secretion from bovine adrenal chromaffin cells was suppressed by beta -eudesmol by inhibition of Ca2+ influx. alpha -Eudesmol, a structural isomer of beta -eudesmol, was also shown to be a P/Q-type Ca2+ channel blocker (Asakura et al., 2000).

In light of their demonstrated beneficial effects, neurotrophic factors were suggested as potential therapeutic agents for the treatment of such neurological diseases as Alzheimer's and Parkinson's disease. Since these factors are polypeptides of high molecular weight, they cannot cross the blood-brain barrier and are easily proteolyzed when administrated peripherally. A useful strategy for addressing this drug delivery problem is the use of small organic compounds, which themselves either directly maintain neuronal function or up-regulate neurotrophic factors. To date, small molecules such as AIT-082 and SR57746A are known to be promising NGF-like agonists or NGF inducers (Xie and Longo, 2000). In the present study, we report the mechanism by which beta -eudesmol promotes neurite outgrowth in PC-12 cells.

    Experimental Procedures
Top
Abstract
Introduction
Experimental Procedures
Results
Discussion
References

Materials. beta -Eudesmol, propidium iodide, and GF109203X were purchased from Wako Pure Chemicals (Tokyo, Japan). NGF, carbachol, W7, and adenosine deaminase were obtained from Sigma Chemical Co. (St. Louis, MO), and H89 was acquired from Seikagaku Corporation (Tokyo, Japan). Fura 2-acetoxymethylester and fluo 3 were purchased from Dojindo (Kumamoto, Japan), and U-73122 and U-73343 were purchased from Biomol (Plymouth Meeting, PA). [3H]inositol (23.4 Ci/mmol) was obtained from PerkinElmer Life Sciences (Boston, MA). The anion exchange column (AG1 × 8) and PD98059 were purchased from Bio-Rad (Hercules, CA) and Cell Signaling (Beverly, MA), respectively.

Cell Culture. PC-12 cells were obtained from the Japanese Cancer Research Bank (Tokyo, Japan) and were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heat-inactivated fetal calf serum (Cell Culture Laboratory, Cleveland, OH), 5% heat-inactivated horse serum (Invitrogen, Grand Island, NY), penicillin (50 units/ml), and streptomycin (50 µg/ml) in a 5% CO2 incubator at 37°C.

Evaluation of Neurite Outgrowth. PC-12 cells (1 × 105 cells/ml) were seeded onto 24-well plates and were cultured for 1 day, after which time drugs were added and the cells cultured for an additional 1 to 2 days. The cells were then fixed with 2% paraformaldehyde (Wako Pure Chemicals) in phosphate-buffered saline (PBS), and cell morphology was assessed under a phase-contrast microscope. Neurite extension from PC-12 cells was regarded as an index of neuronal differentiation (Obara et al., 1998). Processes with a length equivalent to one or more diameters of the cell body were regarded as neurites. The differentiation of PC-12 cells was evaluated by examining the proportion of neurite-bearing cells to total cells in randomly selected fields. The mean differentiation score was obtained for more than a 100 PC-12 cells in each well. Data were expressed as the means ± S.E.M. of three different wells from a single culture.

Measurement of [3H]Thymidine Incorporation. PC-12 cells were seeded onto 24-well plates (1 × 105 cell/ml), and the following day, drugs together with [3H]thymidine (1 µCi/well) (Amersham Biosciences, Piscataway, NJ) were added, and the cells were cultured for an additional 1 to 2 days. After washing twice with ice-cold PBS, the reaction was terminated by the addition of 5% trichloroacetic acid, after which time the plates were kept at 4°C for 60 min. After three washes with ethanol, the radioactivity of [3H]thymidine in the cell lysates was determined by scintillation counting. Data were expressed as the percentage of control.

MTT Assay. PC-12 cells were seeded into 96-well plates (200 µl/well) at a density of 5 × 106 cells/ml. At the end of the drug incubation period, MTT (0.1 mg) (Dojindo) was added to each well, and the plates incubated for an additional 4 h at 37°C. After centrifugation at 350g for 5 min, the medium was replaced with dimethyl sulfoxide. The absorbance of reduced MTT at 595 nm was measured with a plate reader.

Measurement of Intracellular Free-Ca2+ Concentration by Fura 2. Intracellular free-Ca2+ concentration ([Ca2+]i) was measured by the fura 2 assay, as previously described (Obara et al., 1999b). Briefly, semiconfluent PC-12 cells cultured in a 150-mm dish were collected by gentle pipetting and were washed with a modified tyrode buffer (137 mM NaCl, 2.7 mM KCl, 1 mM MgCl2, 0.18 mM CaCl2, 5.6 mM glucose, 10 mM HEPES, pH 7.4). The cells were then incubated with fura 2-acetoxymethylester (2 µM) at 37°C for 30 min, after which time the cells were washed twice with buffer and the fluorescence intensity of fura 2 (excitation wavelength at 340 and 380 nm and emission wavelength at 510 nm) was measured with a fluorescence spectrophotometer (F-2000; Hitachi, Tokyo, Japan). In our preliminary experiments, the Ca2+ responsiveness to beta -eudesmol in these suspended PC-12 cells was nearly equivalent to that seen in attached cells (data not shown).

Measurement of Ca2+ Release from Sarcoplasmic Reticulum Vesicles by Fluo 3. Sarcoplasmic reticulum vesicles were prepared from rabbit skeletal muscle, according to the method described by Kim et al. (1983), in the presence of the protease inhibitors aprotinin (76.8 µM) (Sigma Chemical Co.) and benzamidine (0.83 mM) (Sigma Chemical Co.). Briefly, rabbit white muscle was homogenized in 5 volumes of 5.0 mM Tris-maleate, pH 7.0, and centrifuged at 5000g for 15 min. The supernatant was centrifuged at 12,000g for 30 min. The pellet was suspended in 5.0 mM Tris-maleate containing 90 mM KCl and was centrifuged at 70,000g for 40 min. The pellet obtained after this high-speed spin, which contained the heavy fraction of sarcoplasmic reticulum, was resuspended and stored at -80°C. The protein concentration of the pellet was determined by the method previously described by Bradford (1976), using bovine serum albumin (BSA) as the standard.

The change in the extravesicular free-Ca2+ concentration was monitored by the intensity of fluo 3 florescence at 30°C. The assay mixture (final volume, 0.8 ml) contained 3 µM fluo 3, 50 µM CaCl2, 90 mM KCl, 0.5 mM MgCl2, 50 mM MOPS-Tris, pH 7.0, 0.75 mg/ml sarcoplasmic reticulum, 5 mM creatine phosphate (Wako Pure Chemicals), 0.1 mg/ml creatine kinase (Sigma Chemical Co.), and 0.5 mM ATP. The Ca2+ uptake reaction was initiated by the simultaneous addition of creatine kinase and ATP. Once the extravesicular free-Ca2+ concentration was reduced to the steady-state level, drugs were added. The change in the 530-nm fluorescence of fluo 3 at an excitation wavelength of 488 nm was measured by F-2000, as performed in the fura 2 assay.

Measurement of Ca2+-ATPase Activity. Ca2+-ATPase activity in sarcoplasmic reticulum vesicles was measured as follows: Sarcoplasmic reticulum vesicles (40 µg/ml) in 500 µl of basic solution (100 mM MOPS-Tris, pH 7.4, 200 mM KCl, 2.0 mM MgCl2, and 0.4 mM CaCl2) were preincubated in the absence of drugs and ATP at 30°C for 5 min. This was followed by a 5-min incubation in the presence of 400 µl of drugs. The reaction was started by the addition of 100 µl of ATP (10 mM), which was left on the cells for 3 min (final volume, 1.0 ml). ATPase activity was determined by measurement of the amount of liberated phosphates, using the malachite green method as described by Chan et al. (1986).

Measurement of Inositol Phosphates. The accumulation of total inositol phosphates was measured as follows: PC-12 cells were cultured in 12-well plates for 2 days at a density of 4 × 105 cells/ml/well. Cultures were then incubated overnight with [3H]inositol (2 µCi/ml), after which time they were washed twice with serum-free DMEM-HEPES buffer, pH 7.4. They were then preincubated in DMEM-HEPES containing LiCl (10 mM) for 10 min, after which they were incubated with drugs for additional 10 min. The reaction was terminated by the addition of 1 ml of ice-cold 5% trichloroacetic acid after aspiration of the medium. The extracts were washed three times with diethyl ether to remove the trichloroacetic acid. Diethyl ether in the sample was removed by storage at 47°C for 30 min. Total [3H]inositol phosphates were separated by an anion exchange column (AG-1X8, formate form, 100-200 mesh), as previously described (Nakahata et al., 1989).

SDS-Polyacrylamide Gel Electrophoresis and Immunoblotting for Mitogen-Activated Protein Kinase (MAPK) and cAMP-Responsive Element Binding Protein (CREB). Samples used for phospho-MAPK and phospho-CREB detection were prepared as follows: PC-12 cells were seeded onto 6-well plates at a density of 4 × 105 cells/ml. The cells were cultured overnight in serum-free DMEM, after which drugs were added for varying periods of time. The incubation medium was aspirated after the reaction, and the cells were dissolved in Laemmli sample buffer (final concentration, 75 mM Tris-HCl, 2% SDS, 15% glycerol, 3% 2-mercaptoethanol, pH 6.8) and boiled at 95°C for 5 min.

Electrophoresis was performed on 11% acrylamide gels. Proteins were transferred electrically from the gel onto a polyvinylidene difluoride membrane (Millipore, Bedford, MA) by the semidry blotting method. The blots were blocked for 2 h with 1% BSA in Tris-buffered saline at 25°C, and incubated with anti-phospho-MAPKs (Thr 202/Tyr 204) antibody (1:2000 dilution) (Cell Signaling) or anti-phospho-CREB (Ser 133) antibody (1:1000 dilution) (Cell Signaling) overnight at 4°C. The blots were washed several times and then incubated at 25°C for 2 h, with a 1:2000 dilution of alkaline phosphatase-conjugated goat anti-rabbit IgG antibody (Cell signaling) in Tris-buffered saline containing 1% BSA. Blots were developed using a chemiluminescence assay kit (Bio-Rad) and visualized by exposing the chemiluminescence from the membrane to Hyperfilm ECL. The densities of the bands corresponding to phospho-MAPK and phospho-CREB were analyzed by densitometry (Advanced American Biotechnology, Fullerton, CA). After immunoblotting, polyvinylidene difluoride membranes were stained with amide black, and confirmation was made that the protein content in all lanes was equivalent.

Immunostaining of Phospho-MAPK and Phospho-CREB. PC-12 cells were seeded onto 24-well plates at a density of 2 × 105 cells/ml. The medium was replaced with serum-free DMEM and the cells were cultivated overnight, after which they were incubated in serum-free DMEM-HEPES containing drugs for 5 min. The cells were then fixed with 2% paraformaldehyde/PBS for 15 min, permeated with 0.5% Triton X-100/PBS for 5 min, and then washed with PBS. After blocking with 5% BSA for 3 h at 37°C, the cells were incubated with anti-phospho-MAPKs antibody (1:500 dilution) or anti-phospho-CREB antibody (1:500 dilution) at 4°C overnight, followed by goat fluorescein-labeled anti-rabbit IgG antibody (1:80 dilution) (Kirkegaard & Perry Laboratories, Inc., Gaithersburg, MD) at 37°C for 60 min. The cells were then incubated with propidium iodide (50 ng/ml) for 30 min to stain the nuclei. The cells were then visualized under a confocal laser microscope (DMRB/E, TCS NT; Leica, Wetzlar, Germany).

Statistical Methods. Data were expressed as the mean values ± S.E.M., and the significant differences were analyzed using an analysis of variance. Tukey's method was used for carrying out the multiple comparisons shown in Fig. 9.

    Results
Top
Abstract
Introduction
Experimental Procedures
Results
Discussion
References

Effects of beta -Eudesmol on Neurite Outgrowth in PC-12 Cells. To investigate the effect of beta -eudesmol on PC-12 cells (Fig. 1), cells were cultured with it at a concentration of 10 to 150 µM for 48 h, and morphological changes were observed under the phase-contrast microscope. beta -Eudesmol promoted neurite extension in PC-12 cells (Fig. 2A). When the percentage of neurite-bearing cells was evaluated, beta -eudesmol, at concentrations of 100 and 150 µM, was found to have significantly promoted neurite extension (EC50, >70 µM) to a degree that was similar to that seen with NGF (Fig. 2B). When cell growth was investigated by [3H]thymidine incorporation, a 48-h incubation with beta -eudesmol (150 µM) was found to have significantly suppressed proliferation (IC50, >105 µM) (Fig. 2C). Since the concentration range that caused neurite outgrowth was similar to the range suppressing proliferation, it was assumed that the differentiation of PC-12 cells was due to the arrest of cell growth. A cytotoxic effect was not revealed in this concentration range, as determined by the MTT assay (data not shown).


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 1.   The chemical structure of beta -eudesmol.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 2.   Effect of beta -eudesmol on neurite outgrowth in PC-12 cells. A, morphological change in PC-12 cells induced by beta -eudesmol. PC-12 cells were cultured in the presence or absence of beta -eudesmol (150 µM) for 48 h, and their morphological appearance was then observed under phase-contrast microscopy. Scale bar is 100 µm. B, evaluation of neurite outgrowth in PC-12 cells induced by beta -eudesmol. PC-12 cells were cultured with beta -eudesmol at indicated concentrations or NGF (50 ng/ml) for 48 h, and the percentage of neurite-bearing cells was then calculated as described under Experimental Procedures. Values are the means ± S.E.M. of three different wells from a single culture. beta -Eudesmol (100 and 150 µM) significantly promoted neurite outgrowth from PC-12 cells. *, P < 0.05 versus control without drug. C, effect of beta -eudesmol on [3H]thymidine incorporation in PC-12 cells. PC-12 cells were cultured in the presence of beta -eudesmol (10-150 µM) or NGF (50 ng/ml) together with [3H]thymidine for 48 h, and then incorporated [3H]thymidine was measured. Values are the means ± S.E.M. of three different wells from a single culture. beta -Eudesmol (150 µM) significantly suppressed [3H]thymidine incorporation. *, P < 0.05 versus control without drug.


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 3.   Effect of beta -eudesmol on [Ca2+]i in PC-12 cells. The [Ca2+]i level was monitored by using the fura 2 assay, as described under Experimental Procedures. A, typical responses to carbachol (100 µM) and beta -eudesmol (10-150 µM). B, concentration-dependent increase in [Ca2+]i in response to beta -eudesmol. Data are expressed as the beta -eudesmol-induced increase in [Ca2+]i (Delta [Ca2+]i). Values are the means ± S.E.M. of three independent determinations. beta -Eudesmol at 100 µM and 150 µM significantly increased [Ca2+]i. *, P < 0.05 versus control without drug.

[Ca2+]i Increase by beta -Eudesmol Mediated by an Activation of Phosphoinositide-Specific Phospholipase C. To examine the mechanism of beta -eudesmol-signaling, [Ca2+]i was measured by the fura 2 assay. beta -Eudesmol caused an [Ca2+]i elevation in a concentration-dependent manner in PC-12 cells. The effects of beta -eudesmol at concentrations of 100 and 150 µM were significant, and the maximum response of beta -eudesmol was as large as that seen with carbachol (100 µM). When extracellular Ca2+ was removed by EGTA, the increase in [Ca2+]i was partially inhibited (this inhibition was not statistically significant), although the preponderance of the [Ca2+]i increase remained (Fig. 4). These results suggest that the [Ca2+]i elevation induced by beta -eudesmol primarily resulted from Ca2+ release from intracellular Ca2+ stores in the PC-12 cells.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 4.   Effect of beta -eudesmol on [Ca2+]i under extracellular Ca2+-free conditions in PC-12 cells. A, beta -eudesmol (150 µM) was added in the presence or absence of EGTA (0.5 mM), and the [Ca2+]i level was monitored using the fura 2 assay as shown in Fig. 3. B, effect of removal of extracellular Ca2+ on beta -eudesmol (150 µM)-induced [Ca2+]i elevation. Values are the means ± S.E.M. of three independent determinations.

The involvement of the inositol-(1,4,5)-trisphosphate receptor in beta -eudesmol-evoked Ca2+ release was examined under extracellular Ca2+-free conditions in PC-12 cells. The PI-PLC inhibitor U-73122, at a concentration of 2 µM, inhibited the maximum response of beta -eudesmol (150 µM) by about 50%, compared with an inactive form of the inhibitor U-73343 (2 µM) (Fig. 5A). U-73122 (2 µM) also abolished both the carbachol and ATP-induced [Ca2+]i increases in PC-12 cells (data not shown). When PI-hydrolysis was investigated in DMEM containing 1.8 mM Ca2+, beta -eudesmol and carbachol resulted in a significant accumulation in PC-12 cells of the total inositol phosphates by 4.0 and 10.4 times, respectively (Fig. 5B). We also investigated Ca2+ release from sarcoplasmic reticulum vesicles on which the ryanodine receptor type I is abundantly expressed by using fluo 3 Ca2+ indicator, but no Ca2+ release was observed in response to beta -eudesmol (data not shown). Furthermore, beta -eudesmol did not inhibit Ca2+-ATPase activity, as determined by the malachite green method (data not shown), indicating that beta -eudesmol did not directly interact with either the ryanodine receptor or the Ca2+ pump. These results strongly suggest that Ca2+ release induced by beta -eudesmol was due to the promotion of PI-hydrolysis.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 5.   Involvement of PI-PLC in beta -eudesmol-induced Ca2+ release in PC-12 cells. A, inhibitory effect of U-73122 on beta -eudesmol-induced Ca2+ release. PC-12 cells were preincubated with U-73343 (2 µM) (a) or U-73122 (2 µM) (b) for 1 min before the addition of beta -eudesmol (150 µM) under extracellular Ca2+-free conditions. B, effect of beta -eudesmol on PI-hydrolysis. PC-12 cells were incubated with carbachol (100 µM) or beta -eudesmol (50-150 µM) for 10 min in DMEM containing 1.8 mM Ca2+, and total inositol phosphate accumulation was measured as described. Values are the means ± S.E.M. of three different wells from a single culture. The maximum y-values in these beta -eudesmol and carbachol graphs are 4000 and 8000, respectively. beta -Eudesmol and carbachol significantly increased the accumulation of total inositol phosphates. *, P < 0.05 versus control without drug.

Involvement of MAPK and CREB Activation in beta -Eudesmol-Signaling in PC-12 Cells. Since MAPK plays a central role in NGF-induced neurite outgrowth (Cowley et al., 1994), we wished to determine whether MAPK activation was involved in beta -eudesmol-induced neurite outgrowth in PC-12 cells. After incubation with beta -eudesmol (150 µM) for 5 min, phospho-MAPK was clearly detected in the nuclei of PC-12 cells by immunostaining (Fig. 6A). In addition, beta -eudesmol (150 µM) promoted the phosphorylation of MAPKs (ERK1 and 2) in a time-dependent manner (Fig. 7). Since CREB regulates the expression of genes that play a role in neuronal functions, such as those encoding catecholamine synthesizing enzymes and choline o-acetyltransferase, the phosphorylation of CREB was also examined. After the cells were incubated with beta -eudesmol (150 µM) for 5 min, phospho-CREB was detected in their nuclei (Fig. 6B). beta -Eudesmol caused the phosphorylation of CREB in a time-dependent manner (Fig. 7). The phosphorylation of both MAPK and CREB that was induced by beta -eudesmol was transient. Both phosphorylations were blocked by PD98059 (50 µM) and U-73122 (2 µM) (Fig. 8A). PD98059 inhibited MAPK (ERK 1, 2) and CREB phosphorylation by 68.7, 59.0, and 43.9%, respectively, whereas U-73122 reduced the degree of phosphorylation by 42.7, 43.8, and 38.2%, respectively. These data indicate that the beta -eudesmol-induced MAPK phosphorylation resulted from activation of PI-PLC and that CREB phosphorylation was dependent on MAPK activation. Furthermore, both the calmodulin (CaM) inhibitor W7 and the protein kinase A (PKA) inhibitor H89 also reversed the phosphorylation of MAPK and CREB in a concentration-dependent manner (1-10 µM) (Fig. 8, B and C). W7 (10 µM) inhibited MAPK (ERK 1, 2) and CREB phosphorylation by 80.9, 69.5, and 71.0%, respectively, whereas H89 (10 µM) reduced the degree of phosphorylation by 67.2, 67.7, and 55.0%, respectively. For determinations of involvements of these molecules, the concentrations of inhibitors used in this study were referred to these articles (Wang et al., 1998; Grewal 2000a,b). On the other hand, the protein kinase C (PKC) inhibitor GF109203X (1 µM) did not affect beta -eudesmol-induced MAPK activation (data not shown). In response to [Ca2+]i elevation, neuronal cells secrete adenine nucleotides such as ATP and adenosine, which promote cAMP accumulation through the adenosine A2a/b receptor (Ohkubo et al., 2000; Kasai et al., 2001). For this reason, we examined the involvement of adenine nucleotides in MAPK activation by using adenosine deaminase (1 unit/ml). However, MAPK phosphorylation induced by eudesmol, was not inhibited by adenosine deaminase (data not shown). These results suggest that the phosphorylation of both MAPK and CREB were mediated through activation of CaM and PKA.


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 6.   Effect of beta -eudesmol on the phosphorylation of MAPK and CREB in PC-12 cells. PC-12 cells were incubated with beta -eudesmol (150 µM) for 5 min, which was followed by their processing for phospho-MAPK (A) and phospho-CREB (B) immunoreactivity as described. Nuclei were stained with propidium iodide.


View larger version (42K):
[in this window]
[in a new window]
 
Fig. 7.   Time-dependent effect of beta -eudesmol on the phosphorylation of MAPK and CREB. PC-12 cells were incubated with NGF (50 ng/ml) for 5 min or beta -eudesmol (150 µM) for 2 to 30 min under serum-free conditions, and bands of phosphorylated MAPK and CREB were detected in cell lysates by Western blotting. Lanes: 1, control; 2, NGF (5 min); 3, beta -eudesmol (2 min); 4, beta -eudesmol (5 min); 5, beta -eudesmol (10 min); 6, beta -eudesmol (30 min).


View larger version (79K):
[in this window]
[in a new window]
 
Fig. 8.   Involvement of PI-PLC, CaM and PKA in beta -eudesmol-signaling. A, inhibitory effects of PD98059 and U-73122 on beta -eudesmol-induced MAPK and CREB phosphorylation. PC-12 cells were preincubated with PD98059 (50 µM) or U-73122 (2 µM) for 10 min, followed by a 5-min incubation with beta -eudesmol (150 µM). The bands of phosphorylated MAPK and CREB in the cell lysates were detected by Western blotting. Lanes: 1, control; 2, PD98059 (50 µM); 3, U-73122 (2 µM); 4, beta -eudesmol (150 µM); 5, beta -eudesmol (150 µM) + PD98059 (50 µM); 6, beta -eudesmol (150 µM) + U-73122 (2 µM). B, inhibitory effect of W7 on beta -eudesmol-induced MAPK and CREB phosphorylation. PC-12 cells, preincubated with W7 (1-10 µM) for 10 min, were incubated with beta -eudesmol (150 µM) for 5 min. Lanes: 1, control; 2, beta -eudesmol (150 µM); 3, W7 (10 µM); 4, beta -eudesmol (150 µM) + W7 (1 µM); 5, beta -eudesmol (150 µM) + W7 (3 µM); 6, beta -eudesmol (150 µM) + W7 (10 µM). C, inhibitory effect of H89 on beta -eudesmol-induced MAPK and CREB phosphorylation. PC-12 cells, preincubated with H89 (1-10 µM) for 10 min, were incubated with beta -eudesmol (150 µM) for 5 min. Lanes: 1, control; 2, beta -eudesmol (150 µM); 3, H89 (10 µM); 4, beta -eudesmol (150 µM) + H89 (1 µM); 5, beta -eudesmol (150 µM) + H89 (3 µM); 6, beta -eudesmol (150 µM) + H89 (10 µM).


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 9.   Involvement of PI-PLC and MAPK in beta -eudesmol-induced neurite outgrowth in PC-12 cells. A, effects of U-73122 and PD98059 on the beta -eudesmol-induced neurite outgrowth in PC-12 cells. PC-12 cells, cultured in medium containing beta -eudesmol (150 µM) for 24 h in the presence or absence of U-73122 (2 µM) or PD98059 (30 µM), were scored according to their degree of neurite outgrowth. Values are the means ± S.E.M. of three different wells from a single culture. beta -Eudesmol significantly promoted neurite outgrowth from PC-12 cells. This effect was significantly inhibited by U-73122 and PD98059. In addition, beta -eudesmol significantly enhanced neurite outgrowth in the presence of U-73122. *, P < 0.05 versus control without drug; dagger , P < 0.05; #, P < 0.05. B, effects of U-73122 and PD98059 on the beta -eudesmol-suppressed [3H]thymidine incorporation in PC-12 cells. PC-12 cells were cultured in medium containing beta -eudesmol (150 µM) and [3H]thymidine for 24 h in the presence or absence of U73122 (2 µM) or PD98059 (30 µM). The radioactivity of incorporated [3H]thymidine was measured as described. Values are the means ± S.E.M. of three different wells from a single culture.

To examine whether PI-PLC and MAPK activation was involved in beta -eudesmol-induced neurite outgrowth in PC-12 cells, the cells were preincubated with U-73122 (2 µM) or PD98059 (30 µM) for 10 min before their culture with beta -eudesmol (150 µM) for 24 h. Neurite outgrowth was significantly inhibited by both U-73122 and PD98059 (Fig. 9A). Although beta -eudesmol treatment resulted in the significant extension of neurites in the presence of U-73122, this did not occur in the presence of PD98059. Furthermore, neither beta -eudesmol (150 µM), U-73122 (2 µM), or PD98059 significantly affected [3H]thymidine incorporation in these cells (Fig. 9B). beta -Eudesmol increased both PI-PLC activity and MAPK phosphorylation, and since both U-73122 and PD98059 significantly inhibited beta -eudesmol-induced neurite outgrowth, it appears that PI-PLC and MAPK play important roles in the differentiation of PC-12 cells.

    Discussion
Top
Abstract
Introduction
Experimental Procedures
Results
Discussion
References

In the present study, we showed that beta -eudesmol caused neurite outgrowth from PC-12 cells and that this effect was mediated by MAPK activation. We also demonstrated that the [Ca2+]i elevation was triggered by the promotion of PI-hydrolysis, followed by the phosphorylation of MAPK and CREB.

The concentration range of beta -eudesmol that resulted in neurite outgrowth enhancement was similar to the concentration that suppressed [3H]thymidine incorporation, suggesting that the arrest of proliferation triggered cellular differentiation. Furthermore, the fact that the concentrations of beta -eudesmol that produced statistically significant changes in neurite outgrowth and [Ca2+]i elevation were also equivalent suggested that Ca2+-signaling stimulated neurite outgrowth. With regard to [Ca2+]i elevation, the concentration range of beta -eudesmol that caused inositol phosphate accumulation was lower than the concentration that promoted the [Ca2+]i increase. Therefore, it was assumed that the part of [Ca2+]i elevation was due to other effects of beta -eudesmol, such as its inhibition of Na+, K+-ATPase activity. This speculation was consistent with the data showing that U-73122 did not completely inhibit the [Ca2+]i increase induced by beta -eudesmol (Fig. 5A).

Concerning the mechanism of neurite outgrowth in PC-12 cells, beta -eudesmol triggered the phosphorylation of MAPK (Fig. 6 and 7), which has generally been thought to play a central role in the NGF-induced differentiation of neurons (Cowley et al., 1994). MAPK activation was also assumed to be due to PI-breakdown since U-73122 suppressed the phosphorylation of MAPK (Fig. 8A). Furthermore, neurite outgrowth induced by beta -eudesmol was prevented by PD98059 (Fig. 9). Hence, it was conceivable that MAPK activation was responsible for beta -eudesmol-induced neurite outgrowth. Nevertheless, it is generally accepted that sustained MAPK phosphorylation is crucial for the differentiation of PC-12 cells that is induced by NGF (Harada et al., 2001). Although our observation (i.e., the transient MAPK phosphorylation induced by beta -eudesmol) is inconsistent with this notion, we speculate that other signaling molecules that also affect neurite extension, such as c-Jun N-terminal kinase or phosphatidylinositol-3-kinase, may account for the transient MAPK phosphorylation.

Starikova et al. (2000) demonstrated that KCl (40 mM) triggered the differentiation of PC-12 cells by inducing Ca2+ influx through a voltage-dependent Ca2+ channel. This result indicated that the [Ca2+]i increase was involved in the differentiation of the cells since an [Ca2+]i increase can induce MAPK activation (Grewal et al., 2000b). In spite of that the Ras/MAPK pathway is an important target for Ca2+-signaling in many cell types and activated via the Ca2+-sensitive tyrosine kinase Pyk2 (Lev et al., 1995), it has been clearly shown that the PKA-dependent mechanism of Rap-1/B-Raf-signaling pathway predominates in Ca2+-induced MAPK activation in PC-12 cells (Grewal et al., 2000a,b). In our study, the CaM inhibitor W7 and the PKA inhibitor H89 reversed beta -eudesmol-induced phosphorylation of both MAPK and CREB (Fig. 8, B and C), suggesting the involvement of Ca2+/CaM and PKA. Since adenylate cyclase types I and VIII are CaM-sensitive, the possibility exists that the increased [Ca2+]i induced by beta -eudesmol stimulated the MAPK cascade via PKA as a result of cAMP accumulation. This speculation is consistent with the report that increased [Ca2+]i promoted phosphorylation of MAPK mediated through the CaM/PKA/Rap-1/B-Raf pathway (Grewal et al., 2000a,b). Further study is needed to confirm the involvement of such molecules (i.e., Rap-1 and B-Raf) in MAPK phosphorylation induced by beta -eudesmol. Regarding Ca2+/CaM-insensitive signaling, it has been shown that PKC is also involved in neurite outgrowth in response to NGF in PC-12 cells, which is mediated through MAPK phosphorylation (Brodie et al., 1999). Although classical and novel PKCs are assumed to be activated as a result of PI-hydrolysis induced by beta -eudesmol, the PKC/MAPK cascade pathway does not play a central role in beta -eudesmol-signaling since PKC inhibitor did not inhibit beta -eudesmol-induced MAPK phosphorylation (Y. Obara, T. Aoki, and M. Kusano, unpublished observation).

beta -Eudesmol also caused the phosphorylation of CREB at Ser 133, which is a key regulatory site for the control of its transcription activity (Fig. 6 and 7). CREB phosphorylation was suppressed by both U-73122 and PD98059 (Fig. 8A), implicating the involvement of PI-hydrolysis and MAPK activation in this suppression. In addition, both W7 and H89 also clearly reversed CREB phosphorylation (Fig. 8B and 8C). So far, it has been shown that the phosphorylation of CREB at Ser 133 occurs via p90 ribosomal S6 kinase (RSK) downstream of MAPK, CaM-kinase, and PKA (Gonzalez and Montminy, 1989; Sheng et al., 1991; Xing et al., 1996). Recently, Impey et al. (1998) showed that the Ca2+-mediated phosphorylation of CREB in PC-12 cells occurred via MAPK-dependent activation of the CREB kinase RSK2. PKA was also required for regulation of the nuclear translocation of MAPK-RSK2, a prerequisite for CREB phosphorylation. Based on this report, we speculate that the phosphorylation of CREB induced by beta -eudesmol is dependent on the MAPK/RSK pathway, which is assumed to be activated via the CaM/PKA pathway, as described above. However, we do not deny the possibility of direct phosphorylation of CREB by CaM-kinase or PKA. It has been shown that NGF potentiates neuronal functions in PC-12 and bovine adrenal chromaffin cells, which is accompanied by the induction of the key enzymes in catecholamine biosynthesis, such as tyrosine hydroxylase and dopamine-beta -hydroxylase, and of ion channels, such as voltage-gated Na+ and Ca2+ channels (Acheson et al., 1984; Bouron et al., 1999). Since one physiological role of CREB in NGF-signaling is assumed to be the induction of a series of these catecholamine-synthesizing enzymes (Ghee et al., 1998), then it follows that these enzymes are up-regulated by beta -eudesmol (i.e., functional differentiation). Further study is necessary to examine the role of beta -eudesmol in the functional differentiation of PC-12 cells.

The concentration-dependence curve of the beta -eudesmol-evoked increase in [Ca2+]i showed a biphasic response in PC-12 cells (Fig. 3). In addition, the [Ca2+]i increase was not completely inhibited by PI-PLC inhibition (Fig. 5A). These results suggest that there are multiple mechanisms responsible for this [Ca2+]i regulation. Previously, Satoh et al. (1992) demonstrated that beta -eudesmol suppressed Na+, K+-ATPase and Ca2+-ATPase activity, with IC50 values of 160 µM and 1.1 mM, respectively. Although the concentration-range of beta -eudesmol within which these inhibitory effects were mediated was higher than that used in the present study, its inhibitory effects on these Ca2+-regulating ion pumps are thought to be one of other mechanisms in the [Ca2+]i increase induced by beta -eudesmol since ouabain caused an increase in [Ca2+]i by inhibition of Na+, K+-ATPase (Hochstrate and Schlue, 2001). In contrast to the results of our study, Tachikawa et al. (2000) demonstrated that beta -eudesmol prevented the Ca2+ influx induced by both acetylcholine and high KCl in a concentration-dependent manner in cultured bovine adrenal chromaffin cells and that the acetylcholine-induced secretion of catecholamines was consequently abolished by beta -eudesmol. One interpretation of these conflicting findings is that high concentrations (100 µM) of beta -eudesmol affect at least two distinct sites that promote Ca2+ release and inhibit Ca2+ influx, respectively, although its effects on Ca2+ release predominates in PC-12 cells. In other words, since Ca2+ release was lacking in bovine adrenal chromaffin cells, it was assumed that the [Ca2+]i increase was not observed (Tachikawa et al., 2000).

PI-PLC is classified into three major groups (beta , gamma , and delta ) on the basis of molecular mass, deduced amino sequence, and immunological cross-activity. So far, 10 different mammalian PI-PLC isoenzymes (beta 1-4, gamma 1-2, and delta 1-4) have been characterized (Rebecchi and Pentyala, 2000). PLC-beta has been shown to be regulated by G-proteins, such as the alpha -subunits of a pertussis toxin-insensitive Gq family of G-proteins and beta gamma -subunits of G-proteins, whereas PLC-gamma was shown to be regulated by tyrosine phosphorylation by the action of tyrosine kinases of growth factor receptors or members of the src family, such as Src and Lyn (Rebecchi and Pentyala, 2000). In contrast to PLC-beta and -gamma isoenzymes, the physiological role and regulation of PLC-delta family isoenzymes have not been determined clearly, despite their wide distribution. It has been shown that PC-12 cells express at least these three PLC isoenzymes (beta , gamma , and delta ) in sufficient quantities to be detected by Western blot (Ryu et al., 1990); however, the detailed expression patterns of the isoenzymes in each family have not been clearly defined. Which isoenzymes of PLC are involved in beta -eudesmol-signaling and whether beta -eudesmol directly activates PLC also remain to be investigated.

In conclusion, our data suggest that beta -eudesmol induces neurite outgrowth in PC-12 cells, which is accompanied by MAPK activation. beta -Eudesmol, being a small molecule, may be a promising lead compound for potentiating neuronal function. In addition, the drug may be useful in helping to clarify the mechanisms underlying neuronal differentiation.

    Footnotes

Accepted for publication February 19, 2002.

Received for publication December 11, 2001.

This work was supported in part by grants-in-aid from the Japan Society for the Promotion of Science (01532 to Yu.O.).

Address correspondence to: Dr. Yutaro Obara, Department of Pharmaceutical Molecular Biology, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba, Aramaki, Aoba-ku, Sendai 980-8578, Japan. E-mail: yutaro{at}mail2.pharm.tohoku.ac.jp

    Abbreviations

NGF, nerve growth factor; AIT-082, 4-[[3-(1,6-dihydro-6-oxo-9-purin-9-yl)-1-oxopropyl]amino]benzoic acid; SR57746A, 1-[2-(naphth-2-yl)ethy]-4-(3-trifluoromethyl phenyl)-1,2,5,6-tetrahydropyridine hydrochloride; GF109203X, 3-[1-[-3-(dimethylaminopropyl]-1H-indol-3-yl]-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione monohydrochloride; W7, N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide hydrochloride; H89, N-[2-(4-bromocinnamylamino)ethyl]-5-isoquinoline; U-73122, 1-[6-[[17beta -methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione; U-73343, 1-[6-[[17beta -3-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-2,5-pyrrolidine-dione; PD98059, 2-(2'-amino-3'-methoxyphenol)-oxanaphthalen-4-one; DMEM, Dulbecco's modified Eagle's medium; PBS, phosphate-buffered saline; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium; BSA, bovine serum albumin; MOPS, 4-morpholinepropanesulfonic acid; MAPK, mitogen-activated protein kinase; CREB, cAMP-responsive element binding protein; PI-PLC, phosphoinositide-specific phospholipase C; [Ca2+]i, intracellular Ca2+ concentration; CaM, calmodulin; PKA, protein kinase A; PKC, protein kinase C; RSK, ribosomal S6 kinase; PC-12, pheochromocytoma cells.

    References
Top
Abstract
Introduction
Experimental Procedures
Results
Discussion
References


0022-3565/02/3013-0803-0811$03.00
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
H. Onozuka, A. Nakajima, K. Matsuzaki, R.-W. Shin, K. Ogino, D. Saigusa, N. Tetsu, A. Yokosuka, Y. Sashida, Y. Mimaki, et al.
Nobiletin, a Citrus Flavonoid, Improves Memory Impairment and A{beta} Pathology in a Transgenic Mouse Model of Alzheimer's Disease
J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 739 - 744.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Nakajima, T. Yamakuni, K. Matsuzaki, N. Nakata, H. Onozuka, A. Yokosuka, Y. Sashida, Y. Mimaki, and Y. Ohizumi
Nobiletin, a Citrus Flavonoid, Reverses Learning Impairment Associated with N-Methyl-D-aspartate Receptor Antagonism by Activation of Extracellular Signal-Regulated Kinase Signaling
J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 784 - 790.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow